Lenzing's Nonwovens Push Meets a Heiligenkreuz Deadline as Goldman Sachs Steps Back
Published on 11/18/2026 at 22:11 | Editorial boerse-global.deLenzing has laid out a two-track agenda for the months ahead: spend EUR 50 million deepening its nonwovens footprint while deciding whether its Heiligenkreuz plant has a future at all. The fiber maker confirmed the investment programme in November, the same month Goldman Sachs disclosed it had trimmed its holding below the 5% reporting threshold.
The stake reduction came to light on 13 November, when the combined position fell from 5.86% to 4.90%. That figure bundles voting rights from shares with positions held through financial instruments. Shares alone accounted for 4.30%, with the remaining 0.60% tied to instruments. The disclosure landed as the stock extended a losing run into a third straight session.
Alabama Takes the Larger Slice
At the heart of the spending plan is Mobile, Alabama, where EUR 27 million will go toward additional specialty fiber capacity, including short-cut fibers for nonwovens. The remaining EUR 23 million covers the previously announced expansion at the company's Lenzing site in Austria.
Should investors sell immediately? Or is it worth buying Lenzing?
Heiligenkreuz, meanwhile, remains unresolved. Several nonbinding purchase offers are on the table, according to a company spokesperson, and management aims to establish by the end of the year whether a viable sale can be struck. Failing that, the plant is slated to close at the end of the first quarter of 2027.
Margins Improve While the Bottom Line Deteriorates
The operational picture for the first nine months of 2026 is mixed. Revenue came in at EUR 1.93 billion, down from the prior-year period, yet adjusted EBITDA reached EUR 353 million and the adjusted margin climbed to 18.3%. Unadjusted EBITDA stood at EUR 316.4 million after restructuring effects drained EUR 36.6 million from the figure.
Those same effects weighed on the net result: the loss after tax widened to EUR 130.3 million from EUR 105 million a year earlier.
For the full year 2026, Lenzing is guiding toward adjusted EBITDA of between EUR 430 million and EUR 460 million — a level above the prior year's showing.
Ad
Lenzing Stock: New Analysis - 18 November
Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
